In humans, point mutations of PLCG2 can lead to autoimmune inflammation, resulting in arthralgia and inflammatory bowel disease, suggesting that point mutations of PLCG2 are an essential mechanism for inducing immune inflammation [33]. Here, PLCG2 is linked to inflammatory bowel disease.